EE9400040A - Composition for ophthalmic use - Google Patents
Composition for ophthalmic useInfo
- Publication number
- EE9400040A EE9400040A EE9400040A EE9400040A EE9400040A EE 9400040 A EE9400040 A EE 9400040A EE 9400040 A EE9400040 A EE 9400040A EE 9400040 A EE9400040 A EE 9400040A EE 9400040 A EE9400040 A EE 9400040A
- Authority
- EE
- Estonia
- Prior art keywords
- composition
- ophthalmic use
- ophthalmic
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9302203A SE501482C2 (en) | 1993-06-24 | 1993-06-24 | Composition for topical administration of bispilocarpic acid diesters to the eye in the form of an aqueous solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9400040A true EE9400040A (en) | 1995-12-15 |
Family
ID=20390417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9400040A EE9400040A (en) | 1993-06-24 | 1994-08-18 | Composition for ophthalmic use |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU6973194A (en) |
| EE (1) | EE9400040A (en) |
| LT (1) | LT3525B (en) |
| SE (1) | SE501482C2 (en) |
| WO (1) | WO1995000144A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0777415A4 (en) * | 1994-07-11 | 1999-06-16 | David W Pate | Anandamide analogue compositions and method of treating intraocular hypertention using same |
| GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
| CA3198795A1 (en) | 2020-11-18 | 2022-05-27 | Jeffrey Becker | Complexing agent salt formulations of pharmaceutical compounds |
| WO2023225113A1 (en) * | 2022-05-18 | 2023-11-23 | Bexson Biomedical, Inc. | Complexing agent salt formulations of pharmaceutical compounds at low stoichiometric ratios |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58126810A (en) * | 1981-12-24 | 1983-07-28 | Kaken Pharmaceut Co Ltd | Anti-inflammatory ophthalmic solution and its manufacturing method |
| TW200402B (en) * | 1990-08-13 | 1993-02-21 | Senju Pharma Co | |
| FI98815C (en) * | 1990-11-30 | 1997-08-25 | Santen Oy | Process for the preparation of novel pharmacologically useful ester derivatives of bispilocarpic acid |
-
1993
- 1993-06-24 SE SE9302203A patent/SE501482C2/en unknown
-
1994
- 1994-06-17 AU AU69731/94A patent/AU6973194A/en not_active Abandoned
- 1994-06-17 WO PCT/FI1994/000270 patent/WO1995000144A1/en not_active Ceased
- 1994-06-23 LT LTIP1970A patent/LT3525B/en not_active IP Right Cessation
- 1994-08-18 EE EE9400040A patent/EE9400040A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LTIP1970A (en) | 1995-01-31 |
| SE9302203L (en) | 1994-12-25 |
| WO1995000144A1 (en) | 1995-01-05 |
| LT3525B (en) | 1995-11-27 |
| SE9302203D0 (en) | 1993-06-24 |
| SE501482C2 (en) | 1995-02-27 |
| AU6973194A (en) | 1995-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI961720L (en) | New composition | |
| BR9402379A (en) | Rubber composition | |
| IL115479A0 (en) | Composition for ophthalmic use | |
| DE69400062D1 (en) | Photopolymerizable composition | |
| DE69419101D1 (en) | HIGHLY PURE THIOL-EN COMPOSITION | |
| DE69416947D1 (en) | Rubber composition | |
| DE59308042D1 (en) | Ophthalmic device | |
| BR9407123A (en) | Herbicidal composition | |
| DK0614607T3 (en) | Herbicide composition | |
| DE69430362D1 (en) | EKTOPARASITICIDAL FORMULATION | |
| EE9400040A (en) | Composition for ophthalmic use | |
| DE69423504D1 (en) | PHOTOPOLYMERIZABLE COMPOSITION | |
| EE9400039A (en) | Composition for ophthalmic use | |
| KR950703340A (en) | Anti-RMS composition | |
| ITMI920612A0 (en) | OPHTHALMIC COMPOSITION | |
| ITMI911049A0 (en) | OPHTHALMIC COMPOSITION | |
| BR9304388A (en) | Therapeutic composition for nasal use | |
| KR940027321U (en) | glasses | |
| KR940021122U (en) | Glasses | |
| LTIP1969A (en) | Composition for ophthalmic use | |
| UA27833C2 (en) | WOOD-GLUE COMPOSITION | |
| DK40893A (en) | MICROBICID COMPOSITION | |
| LT2338B (en) | 5-ARGINILAMINONAFTALIN-1-SULPHAMID DIHIDROCHLORIDES AS SEMI-PREPARATIONS FOR 5-ARGINILAMINONAFTALIN-1-SULPHAMID | |
| DK138293D0 (en) | earmuffs | |
| ITMI942406A0 (en) | SPACER - DISPENSER FOR OPHTHALMIC USE |